Home › Funds › Citigroup Inc › IPA
Citigroup Inc position in IPA
IMMUNOPRECISE ANTIBODIES LTD
Latest position (Q2 2025)7 sh
Reported value held$7
Portfolio Weight0.00%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 7 | $0 | New |
| Q4 2021 | 7 | $0 | Hold |
| Q1 2022 | 7 | $0 | Hold |
| Q2 2022 | 7 | $0 | Hold |
| Q3 2022 | 7 | $0 | Hold |
| Q4 2022 | 7 | $36 | Hold |
| Q1 2023 | 7 | $19 | Hold |
| Q2 2023 | 7 | $21 | Hold |
| Q3 2023 | 7 | $13 | Hold |
| Q4 2023 | 7 | $12 | Hold |
| Q1 2024 | 7 | $11 | Hold |
| Q2 2024 | 7 | $7 | Hold |
| Q3 2024 | 7 | $4 | Hold |
| Q4 2024 | 7 | $3 | Hold |
| Q1 2025 | 7 | $3 | Hold |
| Q2 2025 | 7 | $7 | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.